- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Exstrophy in New Zealand
Total 668 results
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
University of Kansas Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS)Active, not recruitingFacioscapulohumeral Muscular DystrophyUnited States
-
National Institute of Diabetes and Digestive and...TerminatedInterstitial Cystitis | Painful Bladder SyndromeUnited States, Canada
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...UnknownSpinal Cord Injuries | Urinary Bladder, NeurogenicUnited States
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheEnrolling by invitationDuchenne Muscular DystrophyUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Noah Hahn, M.D.AstraZeneca; Hoosier Cancer Research NetworkRecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States
-
Ironwood Pharmaceuticals, Inc.RecruitingInterstitial Cystitis | Bladder Pain SyndromeUnited States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
Stanford UniversityUniversity of Pennsylvania; University of California, Davis; Oregon Health and... and other collaboratorsRecruitingFuchs' Endothelial Dystrophy | Fuchs Dystrophy | FuchsUnited States
-
Northwell HealthWithdrawnInterstitial CystitisUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
GlaxoSmithKlineCompletedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States, Canada
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
Uroplasty, IncCompletedUrinary Bladder, OveractiveUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
Bioniche Life Sciences Inc.TerminatedCarcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, CarcinomaUnited States, Canada, Poland, Germany, Netherlands, United Kingdom
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Poland
-
Sarepta Therapeutics, Inc.Completed
-
University of RochesterCompletedMyotonic DystrophyUnited States
-
University of RochesterNational Institute of Neurological Disorders and Stroke (NINDS); Imsmed IncorporatedCompleted
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Ethicon Endo-SurgeryNovella Clinical; Data & Inference, Inc.CompletedOveractive BladderUnited States
-
PfizerActive, not recruitingMuscular Dystrophy, DuchenneUnited States, Australia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Fidia Farmaceutici s.p.a.RecruitingBladder Carcinoma in Situ (CIS)United States, Spain, Italy, France, Poland
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
Paratek Pharmaceuticals IncCompletedCystitis | Uncomplicated Urinary Tract InfectionUnited States
-
Kowa Research Institute, Inc.RecruitingFuchs Endothelial Corneal DystrophyUnited States, Germany, Spain, Canada, United Kingdom, Denmark
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Columbia UniversityMuscular Dystrophy Association; Stevens Institute of TechnologyCompletedDuchenne Muscular Dystrophy | Spinal Muscular Atrophy Type 3United States
-
National Cancer Institute (NCI)RecruitingStage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditionsUnited States, Puerto Rico
-
MedtronicNeuroCompletedOveractive Bladder | Urgency-frequency Syndrome | Urinary Urge IncontinenceUnited States, Netherlands, Canada, United Kingdom
-
Sarepta Therapeutics, Inc.CompletedMuscular Dystrophy, DuchenneUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Afferent Pharmaceuticals, Inc.TerminatedBladder Pain SyndromeUnited States
-
Virginia Commonwealth UniversityRecruitingCongenital Myotonic Dystrophy | Childhood Myotonic Dystrophy | CDM | CHDMUnited States, Italy